Published by Frank Prenesti on 2nd August 2024
(Sharecast News) - GSK said the US Food and Drug Administration has approved its Jemperli treatment in combination with chemotherapy and then use on its own for adult patients with primary advanced or recurrent endometrial cancer.
URL: http://www.digitallook.com/dl/news/story/34468228/...